This website collects cookies to deliver better user experience. Cookie Policy
Accept
Sign In
The Wall Street Publication
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Reading: Sleep-Apnea Machine Recall Costs Grow, Hitting Philips Shares
Share
The Wall Street PublicationThe Wall Street Publication
Font ResizerAa
Search
  • Home
  • Trending
  • U.S
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
    • Markets
    • Personal Finance
  • Tech
  • Lifestyle
    • Lifestyle
    • Style
    • Arts
  • Health
  • Sports
  • Entertainment
Have an existing account? Sign In
Follow US
© 2024 The Wall Street Publication. All Rights Reserved.
The Wall Street Publication > Blog > Business > Sleep-Apnea Machine Recall Costs Grow, Hitting Philips Shares
Business

Sleep-Apnea Machine Recall Costs Grow, Hitting Philips Shares

Editorial Board Published January 12, 2022
Share
Sleep-Apnea Machine Recall Costs Grow, Hitting Philips Shares
SHARE

Royal Philips PHG -14.65% NV expanded the reach of its already huge recall of breathing-aid machines and said supply-chain strains would hit fourth-quarter sales, sending shares down 15%.

The Dutch healthcare giant initiated a recall last year of certain sleep-apnea and ventilator machines amid concerns that a type of foam used in the devices could degrade and release harmful, possibly cancer-causing particles. At the time it estimated the recall would affect 3 to 4 million devices but on Wednesday it raised that estimate to 5.2 million devices world-wide. That is because it has widened the scope of the recall to include older devices after receiving requests from customers for replacements or repairs for them.

The expansion is the latest twist in a sprawling recall that has sowed worry and frustration among sleep apnea sufferers, many of whom have been forced to choose between forgoing treatment or continuing to use a device that could be causing them harm.

“It’s difficult to deny a patient with an older unit a repair, if they are still using it,” Chief Executive Frans van Houten said on a call with investors. “So we felt that we had to be more lenient on accepting the registrations that were coming through in our database on all their units.” Insurers in the U.S. typically pay for a replacement device every five years, but some customers continue to use devices that are older than this.

Most of the devices affected by the recall are so-called CPAP and BiPAP machines, which regulate breathing by gently pushing air into the lungs through a mask. They are primarily used to treat sleep apnea, a condition that causes sufferers to stop breathing for brief periods while asleep. The recall, first announced in June, also affects some ventilators.

Philips started sending out replacement devices in September and the company said Wednesday that around 700,000 replacement or repaired devices had now reached customers. It said it expects to complete the process in the fourth quarter of 2022.

Concerns center on a sound-damping foam made of a material called polyester-based polyurethane, or PE-PUR, that Philips said can degrade and be inhaled by the user. The company was also worried that the foam could emit harmful gases, which along with the particles could be carcinogenic. The company has since said that laboratory tests by an outside expert found that gases emitted by the PE-PUR foam in the first-generation DreamStation devices, which it says represent the majority of affected devices, didn’t occur at levels that would cause long-term health problems for patients. It is still conducting tests relating to the foam particles, and also on other affected devices, it said.

Patients suffered fresh anxiety in November when the Food and Drug Administration raised concerns that the silicone foam used in the repaired or replaced devices could also release harmful gases. The FDA asked Philips to hire an independent laboratory to run further tests on devices using the new foam to identify any potential safety risks. The agency recommends that patients continue to use devices containing the silicone-based foam as it would be more harmful to stop treatment altogether.

Philips also said Wednesday it would raise the financial provision related to the recall to €725 million, equivalent to about $824 million, up €225 million from the amount it had previously set aside. This mainly relates to the costs of the repair-and-replace program. It doesn’t include any costs from potential legal action arising from the recall.

The update on the recall came as the company cautioned that it now expected sales in the fourth quarter of 2021 to be €4.9 billion, around 10% lower than in the same period a year earlier and around €350 million less than it had previously forecast.

Philips attributed the weaker figures to supply-chain strains, including shortages for electronic components and freight capacity, as well as equipment-installation postponements. The company, whose other products include MRI machines, said those delays arose from Covid-19-related staff shortages, pushing back timelines on installation of hospital equipment. Mr. van Houten said that while the company had expected some Covid-related delays, the rapid rise of the Omicron variant had worsened the situation.

The Covid pandemic has strained global supply chains, causing freight backlogs that have driven up costs. Now, some companies are looking for longer-term solutions to prepare for future supply-chain crises, even if those strategies come at a high cost. Photo Illustration: Jacob Reynolds

Write to Denise Roland at [email protected]

Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

TAGGED:Business NewsPAIDWall Street Publication
Share This Article
Twitter Email Copy Link Print
Previous Article U.S. consumer prices soared 7% in past year, most since 1982 U.S. consumer prices soared 7% in past year, most since 1982
Next Article All the fact-checkers in the world can’t save the public health community’s clown show All the fact-checkers in the world can’t save the public health community’s clown show

Editor's Pick

Nicki Minaj Calls Cardi B’s Daughter ‘Ugly’; Cardi Shoots Again That Nicki’s Son Is Nonverbal Because of Drug Use Throughout Being pregnant

Nicki Minaj Calls Cardi B’s Daughter ‘Ugly’; Cardi Shoots Again That Nicki’s Son Is Nonverbal Because of Drug Use Throughout Being pregnant

Studying Time: 3 minutes The Nicki Minaj vs. Cardi B beef has been occurring for years. Like, mainly for so…

By Editorial Board 4 Min Read
Jordan Peterson Hospitalized, ‘Close to Loss of life’ Amid Weird Eating regimen, ‘A long time of Mould Publicity,’ Daughter Says
Jordan Peterson Hospitalized, ‘Close to Loss of life’ Amid Weird Eating regimen, ‘A long time of Mould Publicity,’ Daughter Says

Studying Time: 3 minutes Based on the most recent replace from his…

5 Min Read
This Miso Candy Potato Soup Is Pure Consolation
This Miso Candy Potato Soup Is Pure Consolation

I’m grateful to stay in a time the place soup season is…

7 Min Read

Oponion

Ex-NFL star Chris Kluwe: ‘No kings, no tyrants—not now, not ever’

Ex-NFL star Chris Kluwe: ‘No kings, no tyrants—not now, not ever’

Chris Kluwe managed to do the unimaginable: make the complete…

February 22, 2025

Oil Rises, Stock Futures Edge Up as Investors Seek Clarity on Ukraine

Stock futures crept higher and oil…

February 16, 2022

Congressional deadlines threaten to sideline Biden social welfare bill

Democrats are facing a slew of…

November 9, 2021

Democrats Push to Revive $250 Billion Tech Investment Bill to Counter China

WASHINGTON—A $250 billion spending initiative to…

January 21, 2022

What a view! Well-known Bay Space nude seashore preserved in $10 million deal

For almost 60 years, a windswept…

April 22, 2025

You Might Also Like

Thales Reinforces its Management in eSIM and IoT Connectivity with a ‘Ready to Use’ Licensed Resolution
Business

Thales Reinforces its Management in eSIM and IoT Connectivity with a ‘Ready to Use’ Licensed Resolution

At a time when billions of linked objects are reshaping industries, Thales has achieved a vital safety certification for its…

4 Min Read
Soracom IoT Platform Achieves SOC 2 Kind 2 Compliance for Safety, Availability, and Confidentiality
Business

Soracom IoT Platform Achieves SOC 2 Kind 2 Compliance for Safety, Availability, and Confidentiality

Soracom, Inc., right now introduced that it has efficiently achieved System and Group Controls (SOC) 2 Kind 2 compliance, reinforcing…

2 Min Read
Mobile IoT Module Shipments Grew 23% in Q1 2025 as US–China tensions affect vendor panorama
Business

Mobile IoT Module Shipments Grew 23% in Q1 2025 as US–China tensions affect vendor panorama

In brief Shipments of mobile IoT modules and chipsets grew 23% year-over-year in Q1 2025, based on IoT Analytics’ International…

20 Min Read
Prime 7 Visitor Posting Marketplaces to Purchase Visitor Posts That Drive Search engine optimization Outcomes
Business

Prime 7 Visitor Posting Marketplaces to Purchase Visitor Posts That Drive Search engine optimization Outcomes

Utilizing a visitor posting market helps you overlook all that like a nasty nightmare. However how do you discover probably…

14 Min Read
The Wall Street Publication

About Us

The Wall Street Publication, a distinguished part of the Enspirers News Group, stands as a beacon of excellence in journalism. Committed to delivering unfiltered global news, we pride ourselves on our trusted coverage of Politics, Business, Technology, and more.

Company

  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • WP Creative Group
  • Accessibility Statement

Contact

  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability

Term of Use

  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices

© 2024 The Wall Street Publication. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?